{"id":9219,"date":"2024-04-29T15:07:10","date_gmt":"2024-04-29T20:07:10","guid":{"rendered":"https:\/\/lancomedicalgroup.com\/?p=9219"},"modified":"2024-05-02T13:06:25","modified_gmt":"2024-05-02T18:06:25","slug":"lanco-medical-group-topalliance","status":"publish","type":"post","link":"https:\/\/lancomedicalgroup.com\/es\/lanco-medical-group-topalliance\/","title":{"rendered":"Lanco Medical Group facilita el acceso al tratamiento inicial aprobado por la FDA para el carcinoma nasofar\u00edngeo en Centroam\u00e9rica."},"content":{"rendered":"<p class=\"wp-block-paragraph\">El anuncio de\u00a0 <strong>Biociencias de TopAlliance<\/strong>La aprobaci\u00f3n por parte de la FDA de LOQTORZI\u2122 (toripalimab-tpzi), una filial de propiedad total de Junshi Biosciences, supone un \u00e9xito en el tratamiento del carcinoma nasofar\u00edngeo (CNF). <strong>Este tratamiento, el primero y \u00fanico aprobado por la FDA para esta afecci\u00f3n, estar\u00e1 ahora disponible en Centroam\u00e9rica gracias a la s\u00f3lida plataforma y la presencia regional de Lanco Medical Group, lo que garantiza que este tratamiento vital ya no sea necesario.<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">TopAlliance Biosciences conf\u00eda en nosotros <strong>Grupo M\u00e9dico Lanco<\/strong> Capacidad para desenvolverse en la complejidad operativa y regulatoria de Centroam\u00e9rica, garantizando que LOQTORZI\u2122 pueda tener el m\u00e1ximo impacto posible, salvando m\u00e1s vidas a trav\u00e9s de un acceso m\u00e1s amplio y eficaz.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Este es un paso importante en la direcci\u00f3n correcta en nuestro compromiso continuo de transformar la atenci\u00f3n m\u00e9dica y mejorar la calidad de vida en Am\u00e9rica Latina, en consonancia con nuestra visi\u00f3n de garantizar el acceso a tratamientos sostenibles, avanzados y de vanguardia para todos los pacientes de la regi\u00f3n.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><a href=\"https:\/\/www.topalliancebio.com\/\"><img fetchpriority=\"high\" decoding=\"async\" width=\"800\" height=\"400\" src=\"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/05\/TOPALLIANCE.jpg\" alt=\"\" class=\"wp-image-9235\" srcset=\"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/05\/TOPALLIANCE.jpg 800w, https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/05\/TOPALLIANCE-18x9.jpg 18w\" sizes=\"(max-width: 800px) 100vw, 800px\" \/><\/a><\/figure>","protected":false},"excerpt":{"rendered":"<p>El anuncio de TopAlliance Biosciences, filial de Junshi Biosciences, sobre la aprobaci\u00f3n por la FDA de LOQTORZI\u2122 (toripalimab-tpzi), representa un \u00e9xito en el tratamiento del carcinoma nasofar\u00edngeo (CNF). Este tratamiento, el primero y \u00fanico aprobado por la FDA para esta afecci\u00f3n, estar\u00e1 ahora disponible en Centroam\u00e9rica gracias a la s\u00f3lida plataforma y la presencia regional de Lanco Medical Group, lo que garantiza que este tratamiento vital ya no sea necesario. TopAlliance Biosciences confi\u00f3 en la capacidad de Lanco Medical Group para gestionar la complejidad operativa y regulatoria en Centroam\u00e9rica, asegurando que LOQTORZI\u2122 tenga el m\u00e1ximo impacto posible, salvando m\u00e1s vidas mediante un acceso m\u00e1s amplio y efectivo. Este es un paso significativo en la direcci\u00f3n correcta en nuestro compromiso continuo de transformar la atenci\u00f3n m\u00e9dica y mejorar la calidad de vida en Latinoam\u00e9rica, en consonancia con nuestra visi\u00f3n de garantizar el acceso a tratamientos sostenibles, avanzados y de vanguardia para todos los pacientes de la regi\u00f3n.<\/p>","protected":false},"author":1,"featured_media":9220,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81],"tags":[83,79],"class_list":["post-9219","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-alianzas-estrategicas","tag-lmg","cms-has-post-thumbnail"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>LMG Treatment for Nasopharyngeal Carcinoma in Central America<\/title>\n<meta name=\"description\" content=\"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lancomedicalgroup.com\/es\/lanco-medical-group-topalliance\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LMG Treatment for Nasopharyngeal Carcinoma in Central America\" \/>\n<meta property=\"og:description\" content=\"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lancomedicalgroup.com\/es\/lanco-medical-group-topalliance\/\" \/>\n<meta property=\"og:site_name\" content=\"Lanco Medical Group\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-29T20:07:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-02T18:06:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1350\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lmgroup\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"lmgroup\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/\"},\"author\":{\"name\":\"lmgroup\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/#\\\/schema\\\/person\\\/4997fb29067ac50fee9d4129dfd7ebfd\"},\"headline\":\"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.\",\"datePublished\":\"2024-04-29T20:07:10+00:00\",\"dateModified\":\"2024-05-02T18:06:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/\"},\"wordCount\":155,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lancomedicalgroup.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/lanco-medical-group-TopAlliance.jpg\",\"keywords\":[\"Alianzas Estrat\u00e9gicas\",\"LMG\"],\"articleSection\":[\"News\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/\",\"url\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/\",\"name\":\"LMG Treatment for Nasopharyngeal Carcinoma in Central America\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/lancomedicalgroup.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/lanco-medical-group-TopAlliance.jpg\",\"datePublished\":\"2024-04-29T20:07:10+00:00\",\"dateModified\":\"2024-05-02T18:06:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/#\\\/schema\\\/person\\\/4997fb29067ac50fee9d4129dfd7ebfd\"},\"description\":\"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/lancomedicalgroup.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/lanco-medical-group-TopAlliance.jpg\",\"contentUrl\":\"https:\\\/\\\/lancomedicalgroup.com\\\/wp-content\\\/uploads\\\/2024\\\/04\\\/lanco-medical-group-TopAlliance.jpg\",\"width\":1080,\"height\":1350},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/lanco-medical-group-topalliance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inicio\",\"item\":\"https:\\\/\\\/lancomedicalgroup.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/#website\",\"url\":\"https:\\\/\\\/lancomedicalgroup.com\\\/\",\"name\":\"Lanco Medical Group\",\"description\":\"Together, we do health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lancomedicalgroup.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/lancomedicalgroup.com\\\/#\\\/schema\\\/person\\\/4997fb29067ac50fee9d4129dfd7ebfd\",\"name\":\"lmgroup\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g\",\"caption\":\"lmgroup\"},\"sameAs\":[\"https:\\\/\\\/lancomedicalgroup.com\"],\"url\":\"https:\\\/\\\/lancomedicalgroup.com\\\/es\\\/author\\\/lmgroup\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LMG Treatment for Nasopharyngeal Carcinoma in Central America","description":"Lanco Medical Group facilita el acceso al tratamiento inicial aprobado por la FDA para el carcinoma nasofar\u00edngeo en Centroam\u00e9rica.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lancomedicalgroup.com\/es\/lanco-medical-group-topalliance\/","og_locale":"es_ES","og_type":"article","og_title":"LMG Treatment for Nasopharyngeal Carcinoma in Central America","og_description":"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.","og_url":"https:\/\/lancomedicalgroup.com\/es\/lanco-medical-group-topalliance\/","og_site_name":"Lanco Medical Group","article_published_time":"2024-04-29T20:07:10+00:00","article_modified_time":"2024-05-02T18:06:25+00:00","og_image":[{"width":1080,"height":1350,"url":"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg","type":"image\/jpeg"}],"author":"lmgroup","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"lmgroup","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#article","isPartOf":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/"},"author":{"name":"lmgroup","@id":"https:\/\/lancomedicalgroup.com\/#\/schema\/person\/4997fb29067ac50fee9d4129dfd7ebfd"},"headline":"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America.","datePublished":"2024-04-29T20:07:10+00:00","dateModified":"2024-05-02T18:06:25+00:00","mainEntityOfPage":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/"},"wordCount":155,"commentCount":0,"image":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#primaryimage"},"thumbnailUrl":"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg","keywords":["Alianzas Estrat\u00e9gicas","LMG"],"articleSection":["News"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/","url":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/","name":"LMG Treatment for Nasopharyngeal Carcinoma in Central America","isPartOf":{"@id":"https:\/\/lancomedicalgroup.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#primaryimage"},"image":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#primaryimage"},"thumbnailUrl":"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg","datePublished":"2024-04-29T20:07:10+00:00","dateModified":"2024-05-02T18:06:25+00:00","author":{"@id":"https:\/\/lancomedicalgroup.com\/#\/schema\/person\/4997fb29067ac50fee9d4129dfd7ebfd"},"description":"Lanco Medical Group facilita el acceso al tratamiento inicial aprobado por la FDA para el carcinoma nasofar\u00edngeo en Centroam\u00e9rica.","breadcrumb":{"@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#primaryimage","url":"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg","contentUrl":"https:\/\/lancomedicalgroup.com\/wp-content\/uploads\/2024\/04\/lanco-medical-group-TopAlliance.jpg","width":1080,"height":1350},{"@type":"BreadcrumbList","@id":"https:\/\/lancomedicalgroup.com\/lanco-medical-group-topalliance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inicio","item":"https:\/\/lancomedicalgroup.com\/"},{"@type":"ListItem","position":2,"name":"Lanco Medical Group Facilitates Access to FDA-Approved Primer Treatment for Nasopharyngeal Carcinoma in Central America."}]},{"@type":"WebSite","@id":"https:\/\/lancomedicalgroup.com\/#website","url":"https:\/\/lancomedicalgroup.com\/","name":"Lanco Medical Group","description":"JUNTOS, S\u00ed hacemos salud","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lancomedicalgroup.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/lancomedicalgroup.com\/#\/schema\/person\/4997fb29067ac50fee9d4129dfd7ebfd","name":"grupo lm","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b9ad9000ff71051ee472e2be6b59fbc4b4c9fd29a230ede262f79842b1ea57dc?s=96&d=mm&r=g","caption":"lmgroup"},"sameAs":["https:\/\/lancomedicalgroup.com"],"url":"https:\/\/lancomedicalgroup.com\/es\/author\/lmgroup\/"}]}},"_links":{"self":[{"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/posts\/9219","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/comments?post=9219"}],"version-history":[{"count":11,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/posts\/9219\/revisions"}],"predecessor-version":[{"id":9238,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/posts\/9219\/revisions\/9238"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/media\/9220"}],"wp:attachment":[{"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/media?parent=9219"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/categories?post=9219"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lancomedicalgroup.com\/es\/wp-json\/wp\/v2\/tags?post=9219"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}